VEGFA and neoplasm: Increasing evidence suggests that abnormal tumor vasculature can hinder effective cancer therapy; furthermore, VEGF inhibition can transiently normalize tumor vasculature and improve tumor perfusion as well as the delivery of subsequent chemotherapy [27-29].